{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-08-21T12:22:52.091862+00:00",
  "news": [
    {
      "title": "Amgen Inc. $AMGN Shares Acquired by Sumitomo Mitsui Financial Group Inc. - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPMklYNUVsWng0ZWV5ajdBT2FvTmNWVVU0UFpLUGxUVnFBT1BHcnFMTXc5QjBnd3F1WWZDVHVxWlNQaFVNZHUtc3cxSko1SGg1ekRKdkVNT0tTRlVzRzNsQmdrVDVNeGFfVVFMUGRxdGRTOTVEUUhQMUc2VnQ5M29hZl9WYkdndFRWZW5ZY1l3a0pzLS1BdGtYN3ZYU201S201eEIyelhDQWhHdGxZVmUxMFdLZVpJR0RfWmVJY25qbEYzcWNSemZxLVVB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiygFBVV95cUxPMklYNUVsWng0ZWV5ajdBT2FvTmNWVVU0UFpLUGxUVnFBT1BHcnFMTXc5QjBnd3F1WWZDVHVxWlNQaFVNZHUtc3cxSko1SGg1ekRKdkVNT0tTRlVzRzNsQmdrVDVNeGFfVVFMUGRxdGRTOTVEUUhQMUc2VnQ5M29hZl9WYkdndFRWZW5ZY1l3a0pzLS1BdGtYN3ZYU201S201eEIyelhDQWhHdGxZVmUxMFdLZVpJR0RfWmVJY25qbEYzcWNSemZxLVVB?oc=5\" target=\"_blank\">Amgen Inc. $AMGN Shares Acquired by Sumitomo Mitsui Financial Group Inc.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-08-21T10:39:32+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "SINGZYME WINS 2025 AMGEN X NSG GOLDEN TICKET FOR BREAKTHROUGH BIOCONJUGATION PLATFORM - Laotian Times",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPUWE3YTVUNDYtSlg4emNXOXRidUdSdFRRS1I1VFkyVm8tNE1pQktjUXNaVVc0RXJ5RXdsV2VFOWFRTW9pZEs4SE9tSThIaThfYlVtOW56NVlxUlNEY0g5VENuaThIR3VSSmFJMFB6dnpkVEVYQnY1YTVCOERqUjRDZXduZ2NRZVFRdE4zMFVaTGVMc3RKSHN1RmRsYTREZEJ1d0liOUN5VlVoOHFYMFktbjBvLU53UFZDalF1VzJpYw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxPUWE3YTVUNDYtSlg4emNXOXRidUdSdFRRS1I1VFkyVm8tNE1pQktjUXNaVVc0RXJ5RXdsV2VFOWFRTW9pZEs4SE9tSThIaThfYlVtOW56NVlxUlNEY0g5VENuaThIR3VSSmFJMFB6dnpkVEVYQnY1YTVCOERqUjRDZXduZ2NRZVFRdE4zMFVaTGVMc3RKSHN1RmRsYTREZEJ1d0liOUN5VlVoOHFYMFktbjBvLU53UFZDalF1VzJpYw?oc=5\" target=\"_blank\">SINGZYME WINS 2025 AMGEN X NSG GOLDEN TICKET FOR BREAKTHROUGH BIOCONJUGATION PLATFORM</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Laotian Times</font>",
      "published": "2025-08-21T09:38:00+00:00",
      "source": "Laotian Times"
    },
    {
      "title": "Amgen’s Phase 3 Study on Etelcalcetide: A Potential Breakthrough in Pediatric Nephrology - MSN",
      "link": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxNRDlPMnVGZjlYNmFDOGJSYlEyXzcwYWItOUgtNUIxLThFd3picFdpTldDX1F3YTE5T3lZWHdWbkRaTXRPWGJaTFl5UnBjRG5EX3pYR0hQUER0WS1YSXFwbGh0M0FvaW9HM1RBeU1pbHBtUUJHNVdkcThzUldQSjY1d2pOQVZzNE90Q09yLXdtQzFwcDF4Wk9YdDlfWk5VRGFnWDFLOW56UUJLalJTcUU1TnpPYkVBSjRnbVpIY1ZXclhiQkhPUGc4al9nNFN0WTZGYWc5TF83UXlRY0w4Qk1Hemw0WGk?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi5AFBVV95cUxNRDlPMnVGZjlYNmFDOGJSYlEyXzcwYWItOUgtNUIxLThFd3picFdpTldDX1F3YTE5T3lZWHdWbkRaTXRPWGJaTFl5UnBjRG5EX3pYR0hQUER0WS1YSXFwbGh0M0FvaW9HM1RBeU1pbHBtUUJHNVdkcThzUldQSjY1d2pOQVZzNE90Q09yLXdtQzFwcDF4Wk9YdDlfWk5VRGFnWDFLOW56UUJLalJTcUU1TnpPYkVBSjRnbVpIY1ZXclhiQkhPUGc4al9nNFN0WTZGYWc5TF83UXlRY0w4Qk1Hemw0WGk?oc=5\" target=\"_blank\">Amgen’s Phase 3 Study on Etelcalcetide: A Potential Breakthrough in Pediatric Nephrology</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MSN</font>",
      "published": "2025-08-21T07:51:20+00:00",
      "source": "MSN"
    },
    {
      "title": "Precision Trading with Amgen Inc. (AMGN) Risk Zones - news.stocktradersdaily.com",
      "link": "https://news.google.com/rss/articles/CBMiygFBVV95cUxQVDY1MDZ1b0l3RW56Sl9RZWNWTjBzVjZ1N1kwa3R2VDJVemlseVhEdlJBekd2MWpGVGNydnAxUjhYamhMdUtYcnJjYS04SVVFQ0d6dDZUM3ZYSHNTR09icGZodEpJYXlNS25kMjM3Y0JablF3RHhhVWxzalFUWXZnamxuczJfUHVDbGIyNzBxeG5ueUpRN0RvMUhqRHZveTk5Ri1VWWVMdXVJb1Q3OFkzTGg4OGF4UXMyTkhsemFPU2VoOE1jWGtIVURB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiygFBVV95cUxQVDY1MDZ1b0l3RW56Sl9RZWNWTjBzVjZ1N1kwa3R2VDJVemlseVhEdlJBekd2MWpGVGNydnAxUjhYamhMdUtYcnJjYS04SVVFQ0d6dDZUM3ZYSHNTR09icGZodEpJYXlNS25kMjM3Y0JablF3RHhhVWxzalFUWXZnamxuczJfUHVDbGIyNzBxeG5ueUpRN0RvMUhqRHZveTk5Ri1VWWVMdXVJb1Q3OFkzTGg4OGF4UXMyTkhsemFPU2VoOE1jWGtIVURB?oc=5\" target=\"_blank\">Precision Trading with Amgen Inc. (AMGN) Risk Zones</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">news.stocktradersdaily.com</font>",
      "published": "2025-08-21T06:52:01+00:00",
      "source": "news.stocktradersdaily.com"
    },
    {
      "title": "Amgen's ChemoCentryx prevails in investor lawsuit centered on autoimmune drug Tavneos - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQQ1hDaEdTYW9QNHhXZElVLTctaTJKMWNfSzJ1dUl6ZXlSZUF0Q1JoNnNpT0tRM2NVN2xPUkpDSXp0elozalN4ODRWWUhIS3oyNWRQeHFLQW9DVmtRWmNwTjFQZDNISWJWNVFtLWppeEhFU3FJMDQtTTU1ZGhCRktXc0t4ak0xTU9lVV9FYzlHTzJVZ1VLV2kzS1cxdi1hc1AtZjl6TjJZZDVGMG9JUnBhbEZR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQQ1hDaEdTYW9QNHhXZElVLTctaTJKMWNfSzJ1dUl6ZXlSZUF0Q1JoNnNpT0tRM2NVN2xPUkpDSXp0elozalN4ODRWWUhIS3oyNWRQeHFLQW9DVmtRWmNwTjFQZDNISWJWNVFtLWppeEhFU3FJMDQtTTU1ZGhCRktXc0t4ak0xTU9lVV9FYzlHTzJVZ1VLV2kzS1cxdi1hc1AtZjl6TjJZZDVGMG9JUnBhbEZR?oc=5\" target=\"_blank\">Amgen's ChemoCentryx prevails in investor lawsuit centered on autoimmune drug Tavneos</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-08-19T14:13:25+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "US judge overturns Amgen's $50.3 mln loss in cancer drug patent case - Reuters",
      "link": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPMmtjZnZnZXdyRGJKWnpCbDJOWXJMdnhqTlJORXNBTkNFRHpqWk1UYVdleE9OUGpEVWhheUtmUHloVk55OUZ4eVVJUVR1UFhtS2NRT1Z5QnNSTHNLamNuOE9lVHczVnc0a3pjVE5aaThPSmdCb25vMVFFT0ZKWF9iMEtzLTI0cjc0dEVHU1hXMHZZdENWUmpLY2JRM243NXBKWmRlN25lZUYyZGUzX3BjWEkxam8wQQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMitgFBVV95cUxPMmtjZnZnZXdyRGJKWnpCbDJOWXJMdnhqTlJORXNBTkNFRHpqWk1UYVdleE9OUGpEVWhheUtmUHloVk55OUZ4eVVJUVR1UFhtS2NRT1Z5QnNSTHNLamNuOE9lVHczVnc0a3pjVE5aaThPSmdCb25vMVFFT0ZKWF9iMEtzLTI0cjc0dEVHU1hXMHZZdENWUmpLY2JRM243NXBKWmRlN25lZUYyZGUzX3BjWEkxam8wQQ?oc=5\" target=\"_blank\">US judge overturns Amgen's $50.3 mln loss in cancer drug patent case</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-14T19:28:47+00:00",
      "source": "Reuters"
    },
    {
      "title": "Amgen overturns $50 million damages with ‘inequitable conduct’ defence - IAM Patent",
      "link": "https://news.google.com/rss/articles/CBMikgFBVV95cUxQWWFMS1V0M0FfTmU1MHQ0amVjb1NoTmJSV1JzNnJVTUd6YW95VldtaEZILThrTVFlcGdoMENQdlNDaFZVeGd4TXN6b2R4SjNCbEVnZTRKdXNXUlZUaHVIU2VLM19HMmFkYnVMNTd5LTV4bjdfeDRBVEZwdnFNdXJFZnFRcFo1TmUtSExXaFN0bGRaQQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikgFBVV95cUxQWWFMS1V0M0FfTmU1MHQ0amVjb1NoTmJSV1JzNnJVTUd6YW95VldtaEZILThrTVFlcGdoMENQdlNDaFZVeGd4TXN6b2R4SjNCbEVnZTRKdXNXUlZUaHVIU2VLM19HMmFkYnVMNTd5LTV4bjdfeDRBVEZwdnFNdXJFZnFRcFo1TmUtSExXaFN0bGRaQQ?oc=5\" target=\"_blank\">Amgen overturns $50 million damages with ‘inequitable conduct’ defence</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">IAM Patent</font>",
      "published": "2025-08-19T11:31:47+00:00",
      "source": "IAM Patent"
    },
    {
      "title": "Generative AI Tools Support Amgen’s Mission to Serve Patients - Amgen",
      "link": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNMmdNbVVGa2tCTHRkdGFsbm9LaFUyOWFpTXhMeGotQTFoOXpuRFBpemY4b0o1aWRrQ1hHUFZua3hWV3FkWUlUUmUyRXZsbTdzRXV1eDlqcjZEbjZkMnV6SHNqM2c2WE1QS2hEYTdsV2RUMWt6OE9GbjUxaEtUMTYzWEF0NjV3S19kOHRrUTdPQWR2ZVZqVk9DRTh0OHFRTm8?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMinwFBVV95cUxNMmdNbVVGa2tCTHRkdGFsbm9LaFUyOWFpTXhMeGotQTFoOXpuRFBpemY4b0o1aWRrQ1hHUFZua3hWV3FkWUlUUmUyRXZsbTdzRXV1eDlqcjZEbjZkMnV6SHNqM2c2WE1QS2hEYTdsV2RUMWt6OE9GbjUxaEtUMTYzWEF0NjV3S19kOHRrUTdPQWR2ZVZqVk9DRTh0OHFRTm8?oc=5\" target=\"_blank\">Generative AI Tools Support Amgen’s Mission to Serve Patients</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2025-07-08T07:00:00+00:00",
      "source": "Amgen"
    }
  ],
  "product_launches": [
    {
      "title": "Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxONkt3YUVEeUpwTU5LYVgtaTk2THhoMEt3ZUliWC1sWmhTTGR4M0hwaVpFMEFla01mUTdxbGVueWNGVThVT3U1T3R2NTQwaEkxeEI5MjRPMzVQUlhaU3hKNVVqQmFFY3BMQ2c3enphdTVLVy1Wb3dTb0l4Rnk3czFVTVFZbUdvVVJwa1I4Z3FDOFByVDZIV21Ccnk5VTd5U3VtNHhuVDdQUldHNm81YnZ6MHFReDBJNmk1S3BucTJhUlplcnc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwwFBVV95cUxONkt3YUVEeUpwTU5LYVgtaTk2THhoMEt3ZUliWC1sWmhTTGR4M0hwaVpFMEFla01mUTdxbGVueWNGVThVT3U1T3R2NTQwaEkxeEI5MjRPMzVQUlhaU3hKNVVqQmFFY3BMQ2c3enphdTVLVy1Wb3dTb0l4Rnk3czFVTVFZbUdvVVJwa1I4Z3FDOFByVDZIV21Ccnk5VTd5U3VtNHhuVDdQUldHNm81YnZ6MHFReDBJNmk1S3BucTJhUlplcnc?oc=5\" target=\"_blank\">Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-01-28T08:00:00+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "Sandoz files antitrust suit in latest bid to launch biosimilar of Amgen's Enbrel in US - FirstWord Pharma",
      "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5VckVQdjB2RUpTc0p0YU1DYnpKMGJHbUt0b3djeEI1Sk91Mm9NLWJPQmpLUEhNYUtBZ1BUa21RVlQxcEhHdXpMa3dNMUs4NTd5dDhn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5VckVQdjB2RUpTc0p0YU1DYnpKMGJHbUt0b3djeEI1Sk91Mm9NLWJPQmpLUEhNYUtBZ1BUa21RVlQxcEhHdXpMa3dNMUs4NTd5dDhn?oc=5\" target=\"_blank\">Sandoz files antitrust suit in latest bid to launch biosimilar of Amgen's Enbrel in US</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">FirstWord Pharma</font>",
      "published": "2025-04-14T07:00:00+00:00",
      "source": "FirstWord Pharma"
    },
    {
      "title": "Amgen Confirms Launch Of First US Eculizumab Rival - insights.citeline.com",
      "link": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxQVHFOTU9KXzdESTJJc2dLZFF0Q1RMYTFoT3JHeElVd1pxUEdqbDRzdTZkZmQ3eWJZYmpGb1BLMTB6UVctcHVMLWUwNkluT280b215TDNBaFFranlMbll1S2w3QnlJWjFPNDVQZ3ZObmtfZlUxcXZJWEdIaU45Ym1heWJfWUpQTEtZRDNEY281UmprYkZab2RhS05HaUhRTjltZXZ6RG1SRnNlZzRHb05Yc2IwSWRlZHNKZzM1NWF5dzBxbTV2Zlo0blFBU291SkRSUU9QSl91dVJzRVFWakRHNA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQVHFOTU9KXzdESTJJc2dLZFF0Q1RMYTFoT3JHeElVd1pxUEdqbDRzdTZkZmQ3eWJZYmpGb1BLMTB6UVctcHVMLWUwNkluT280b215TDNBaFFranlMbll1S2w3QnlJWjFPNDVQZ3ZObmtfZlUxcXZJWEdIaU45Ym1heWJfWUpQTEtZRDNEY281UmprYkZab2RhS05HaUhRTjltZXZ6RG1SRnNlZzRHb05Yc2IwSWRlZHNKZzM1NWF5dzBxbTV2Zlo0blFBU291SkRSUU9QSl91dVJzRVFWakRHNA?oc=5\" target=\"_blank\">Amgen Confirms Launch Of First US Eculizumab Rival</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">insights.citeline.com</font>",
      "published": "2025-03-05T08:00:00+00:00",
      "source": "insights.citeline.com"
    },
    {
      "title": "Strong first-quarter product sales for Amgen - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5\" target=\"_blank\">Strong first-quarter product sales for Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2025-05-02T07:00:00+00:00",
      "source": "The Pharma Letter"
    },
    {
      "title": "UK court clears the way for Amgen and Samsung to launch biosimilars - Life Sciences Intellectual Property Review",
      "link": "https://news.google.com/rss/articles/CBMisAFBVV95cUxPWkdPRDN3S2JyejdQMF9Dcnlud3hwb0pIaV9BUXBpdE54cW9DUVltNzRNcVM2UjBhd2lCZXc3YXFCR1Zaa2lIdHA5dVJqMFpTa2FPU1Z6Tjh1VVg5aFotTG4xSVdwNGt4OGJ5WXlHSjN4VTJ1a1lPYzMxVFBLeTJ4Z010Z3d4anpvYV9YYkpxczNBLVJkX3I2UVBLOEVUc1hmX3kwbG9KZnZnd2ZBMGt4Qg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisAFBVV95cUxPWkdPRDN3S2JyejdQMF9Dcnlud3hwb0pIaV9BUXBpdE54cW9DUVltNzRNcVM2UjBhd2lCZXc3YXFCR1Zaa2lIdHA5dVJqMFpTa2FPU1Z6Tjh1VVg5aFotTG4xSVdwNGt4OGJ5WXlHSjN4VTJ1a1lPYzMxVFBLeTJ4Z010Z3d4anpvYV9YYkpxczNBLVJkX3I2UVBLOEVUc1hmX3kwbG9KZnZnd2ZBMGt4Qg?oc=5\" target=\"_blank\">UK court clears the way for Amgen and Samsung to launch biosimilars</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Life Sciences Intellectual Property Review</font>",
      "published": "2025-05-22T07:00:00+00:00",
      "source": "Life Sciences Intellectual Property Review"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-08-20",
      "close": 296.45001220703125
    },
    "history": [
      {
        "date": "2025-08-12",
        "close": 284.9800109863281
      },
      {
        "date": "2025-08-13",
        "close": 289.3299865722656
      },
      {
        "date": "2025-08-14",
        "close": 290.2900085449219
      },
      {
        "date": "2025-08-15",
        "close": 296.4700012207031
      },
      {
        "date": "2025-08-18",
        "close": 292.6199951171875
      },
      {
        "date": "2025-08-19",
        "close": 295.54998779296875
      },
      {
        "date": "2025-08-20",
        "close": 296.45001220703125
      }
    ],
    "name": "Amgen Inc."
  }
}